Nasdaq:US$14.76 (+0.01) | HKEX:HK$23.28 (+0.02) | AIM:£2.15 (+0.01)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma